Geron Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (39)

View All

Latest Posts

About This Stock More About This Stock
Thoughts For Thursday: Back From The Holiday With Caution
Article By: TalkMarkets DailyTalk
Thursday, July 6, 2023 6:27 AM EDT
Caution is perhaps what was reflected in yesterday's back from the holiday trading. First there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.
In this article: DAX, QQQ, IWM, GERN, PACB, XLV, CRSP, META Also: GXC, SMH, BWA, GNRC, LVS, USO, XBI
Read
4 Biotech Stocks With Bright Prospects To Buy Amid Recovery
Article By: Zacks Investment Research
Saturday, June 11, 2022 3:00 PM EDT
New drug approvals, acquisitions, and other pipeline developments are back in the spotlight in the biotech industry, following the focus on the development of vaccines and antibody treatments for COVID-19 in the last two years.
In this article: GERN, ALKS, BLU, IMCR
Read
38 Stocks Moving In Wednesday's Pre-Market Session
Article By: Benzinga
Wednesday, August 26, 2020 7:00 AM EDT
Here are the best gainers and losers moving in pre-market.
In this article: CRM, JWN, RIG, IGC, BKYI, SRNE, FLDM, GERN, GEVO, ICON, INTU, URBN, CAAS, KNDI, PPSI, WORX, PSTG, HPE, NAKD, ZSAN, OPGN, VIVE, LPCN, BPTH, IMUX, CWBR, BIGC, SONN, MYT, EVSI, IMVT, SOLO, BLCT, BRQS, OCGN, DFFN, EXPR, XSPA
Read
Geron Soars After Johnson & Johnson Job Posting Mentions Imetelstat
Article By: The Fly
Friday, August 24, 2018 8:43 PM EDT
The move higher in shares of Geron (GERN) is being attributed to a Johnson & Johnson (JNJ) job opening on LinkedIn for an "EMEA Strategic Pricing Manager" role that would "also be accountable for shaping our pricing approach for Imetelstat."
In this article: JNJ, GERN
Read
5 Biomedical Stocks That Are Expected To Surge
Article By: Zacks Investment Research
Tuesday, June 27, 2017 5:01 PM EDT
Every investor struggles with balancing risk and reward when choosing their investments. Biomedical companies are known to offer large capital gains and growth prospects, yet they do not always come to fruition.
In this article: GERN, REGN, KDMN, ENZ, AVXL Also: JNJ
Read
All Posts

Latest Tweets for $GERN

No tweets yet!

PARTNER HEADLINES